Search

Your search keyword '"Ferket, Bart S."' showing total 224 results

Search Constraints

Start Over You searched for: Author "Ferket, Bart S." Remove constraint Author: "Ferket, Bart S." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
224 results on '"Ferket, Bart S."'

Search Results

2. Parent-Reported Clinical Utility of Pediatric Genomic Sequencing.

3. Employing effective recruitment and retention strategies to engage a diverse pediatric population in genomics research

4. Longitudinal Plasma Metabolome Patterns and Relation to Kidney Function and Proteinuria in Pediatric CKD

5. US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)

7. The TeleKidSeq pilot study: incorporating telehealth into clinical care of children from diverse backgrounds undergoing whole genome sequencing

8. Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program

9. Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD

11. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease

12. Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network

13. Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation

14. Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta‐Regression Analysis

17. Correction to: The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

22. Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program

23. Association of Integrated Proteomic and Metabolomic Modules with Risk of Kidney Disease Progression

25. Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression

27. Abstract P140: Potential Mediators for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis

30. Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network

31. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods

32. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease

37. Additional file 1 of The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

40. Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey

44. The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

45. The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

46. Developing an Institute for Health Care Delivery Science: successes, challenges, and solutions in the first five years

47. The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

48. Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals

50. Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation

Catalog

Books, media, physical & digital resources